UFP Technologies (UFP Technologies) Cash And Cash Equivalents

: $5.3 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

UFP Technologies's quarterly cash and cash equivalents increased from Jun. 2023 ($5.29 Mil) to Sep. 2023 ($6.38 Mil) but then stayed the same from Sep. 2023 ($6.38 Mil) to Dec. 2023 ($5.26 Mil).

UFP Technologies's annual cash and cash equivalents declined from Dec. 2021 ($11.12 Mil) to Dec. 2022 ($4.45 Mil) but then increased from Dec. 2022 ($4.45 Mil) to Dec. 2023 ($5.26 Mil).

UFP Technologies Cash And Cash Equivalents Historical Data

The historical data trend for UFP Technologies's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UFP Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

3.74

24.23

11.12

4.45

5.26

UFP Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents																4.45	6.50	5.29	6.38	5.26

UFP Technologies Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

UFP Technologies (NAS:UFPT) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

UFP Technologies Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of UFP Technologies's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

UFP Technologies (UFP Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » UFP Technologies Inc (NAS:UFPT) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

UFP:Germany

Address

100 Hale Street, Newburyport, MA, USA, 01950-3504

Website

https://www.ufpt.com

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products and packaging utilizing highly specialized foams, films, and plastics primarily for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

Executives

R Jeffrey Bailly	director, 10 percent owner, officer: President and CEO	100 HALE STREET, NEWBURYPORT MA 01950
Mitchell Rock	officer: Vice President	C/O UFP TECHNOLOGIES, INC., 172 EAST MAIN STREET, GEORGETOWN MA 01833
Jason Holt	officer: Vice President	100 HALE STREET, NEWBURYPORT MA 01950
Symeria Hudson	director	100 HALE STREET, NEWBURYPORT MA 01950
Joseph Hassett	director	ONE TECHNOLOGY WAY, NORWOOD MA 02062
Daniel C Croteau	director	C/O LYNCH, BREWER, HOFFMAN & FINK, LLP, 75 FEDERAL STREET, 7TH FLOOR, BOSTON MA 02110
Cynthia L Feldmann	director	17 WINTHROP ROAD, WAYLAND MA 01778
Christopher P. Litterio	officer: Senior Vice President	C/O UFP TECHNOLOGIES, INC., 100 HALE STREET, NEWBURYPORT MA 02143
Ronald J Lataille	officer: Chief Financial Officer
Thomas Oberdorf	director	C/O GETTY IMAGES, INC., 601 N 34TH ST, SEATTLE WA 98103
Marc D Kozin	director
Steve Cardin	officer: Vice President	100 HALE STREET, NEWBURYPORT MA 01950
Daniel J Shaw	officer: Vice President
W David Smith	officer: Vice President	172 EAST MAIN STREET, GEORGETOWN MA 01833
Pierce Robert W Jr	director	C/O UFP TECHNOLOGIES, INC., 172 EAST MAIN STREET, GEORGETOWN MA 01833